"Drug Utilization" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles.
| Descriptor ID |
D004363
|
| MeSH Number(s) |
N04.452.706.477
|
| Concept/Terms |
Drug Utilization- Drug Utilization
- Utilization, Drug
- Drug Utilizations
- Utilizations, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Utilization".
Below are MeSH descriptors whose meaning is more specific than "Drug Utilization".
This graph shows the total number of publications written about "Drug Utilization" by people in this website by year, and whether "Drug Utilization" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 4 | 1 | 5 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 2 | 1 | 3 |
| 2015 | 1 | 1 | 2 |
| 2016 | 3 | 3 | 6 |
| 2017 | 41 | 32 | 73 |
| 2018 | 52 | 28 | 80 |
| 2019 | 22 | 18 | 40 |
| 2020 | 4 | 4 | 8 |
| 2021 | 6 | 7 | 13 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Utilization" by people in Profiles.
-
Patterns of prescription dispensation and over-the-counter medication sales in Sweden during the COVID-19 pandemic. PLoS One. 2021; 16(8):e0253944.
-
Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave. Pharmacoepidemiol Drug Saf. 2021 11; 30(11):1493-1503.
-
Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry. PLoS One. 2021; 16(7):e0254635.
-
Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis. PLoS Med. 2021 07; 18(7):e1003682.
-
COVID-19 Outbreak Impact on Anticoagulants Utilization: An Interrupted Time-Series Analysis Using Health Care Administrative Databases. Thromb Haemost. 2021 08; 121(8):1115-1118.
-
The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review. Microb Drug Resist. 2021 Dec; 27(12):1705-1725.
-
Assessment of Psychotropic Drug Prescribing Among Nursing Home Residents in Ontario, Canada, During the COVID-19 Pandemic. JAMA Intern Med. 2021 06 01; 181(6):861-863.
-
Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives During the Height of the COVID-19 Pandemic in New York City. Arthritis Care Res (Hoboken). 2021 06; 73(6):909-917.
-
COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy. J Gerontol A Biol Sci Med Sci. 2021 05 22; 76(6):1068-1073.
-
Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021 Apr; 57(4):106324.